Archive for October, 2025
-
Accountability Without Authority: Holding Everyone to a Higher Standard
Accountability often brings to mind images of confrontation, discipline, or even public reprimand. In many workplaces, the word has been misused so frequently that it now carries a negative tone. Yet accountability, when practiced with intention and care, is one of the most valuable tools for personal and organizational growth. Rather than a mechanism for blame, it should serve as a structure for clarity, consistency, and shared purpose.
-
GSK CEO Transition: Balancing Legacy, Expectation and Renewal
Leadership transitions in the pharmaceutical industry carry stakes that extend far beyond shareholder headlines. The recent announcement that Emma Walmsley, CEO of GlaxoSmithKline (GSK), will step down at the end of 2025 represents one of those inflection points. Walmsley, who has guided the company since 2017, will remain through September 2026 to support continuity while Chief Commercial Officer Luke Miels takes over as CEO on January 1, 2026.